0:50
Richard Blumenthal
82:14 - 83:05
"I'm concerned about the effects of staffing cuts, shortages in funds for research, various actions taken by this administration that may inhibit or impede the kind of research that is done by the VA in the past. The VA has been a pathbreaker, an innovative force in American medicine."
“I'm concerned about the effects of staffing cuts, shortages in funds for research, various actions taken by this administration that may inhibit or impede the kind of research that is done by the VA in the past. The VA has been a pathbreaker, an innovative force in American medicine.”
- Speaker
- Richard Blumenthal
- Timestamp
- 82:14 – 83:05
- Community
- Alaska News
- Captured at
- July 22, 2026
From the transcript
As I say in my opening statement, I'm concerned about the effects of staffing cuts, shortages in funds for research, various actions taken by this administration that may inhibit or impede the kind of research that is done by the VA in the past. The VA has been a pathbreaker, an innovative force in American medicine. It has been a source of basic science progress and health systems research, um, really a bright star in the constellation of resources in our healthcare system in the United States.
Related Coverage
Senate panel examines VA research funding, hiring delays, and prostate cancer program
The Senate Veterans' Affairs Committee held a broad hearing Wednesday on the future of VA research, covering hiring delays, budget cuts, NIH funding instability, and clinical trial disruptions. Senators also questioned whether a $5 million FY2024 appropriation for the VA prostate cancer precision oncology program was spent as Congress intended.
by Walter AlaskaNews3h ago2 min readAIWashington, District of Columbia
